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Because of its intrinsic quantitative properties, PET permits
measurement of myocardial perfusion and metabolism in abso-
lute terms (i.e., mL/g/min). However, quantification has been
limited by errors produced in image acquisition, selection of
regions of interest, and data analysis. The goal of this study was
to evaluate a newly developed, novel, wavelet-based noise-
reduction approach that can objectively extract biologic signals
hidden within dynamic PET data. Methods: Quantification of
myocardial perfusion using dynamic PET imaging with 82Rb,
H215O, and 13NH3 was selected to evaluate the effects of the
wavelet-based noise-reduction protocol. Dynamic PET data
were fitted to appropriate mathematic models before and after
wavelet-based noise reduction to get flow estimates. Time–
activity curves, precision, accuracy, and differentiating capacity
derived from the wavelet protocol were compared with those
obtained from unmodified data processing. A total of 84 human
studies was analyzed, including 43 at rest (18 82Rb scans, 18
H215O scans, and 7 13NH3 scans) and 41 after coronary hyper-
emia with dipyridamole (17 82Rb scans, 17 H215O scans, and 7
13NH3 scans). Results: For every tracer tested under all condi-
tions, the wavelet method improved the shape of blood and
tissue time–activity curves, increased estimate-to-error ratios,
and maintained fidelity of flow in regions as small as 0.85 cm3.
It also improved the accuracy of flow estimates derived from
82Rb to the level of that achieved with H215O, which was not
affected markedly by the wavelet process. In studies of patients
with coronary disease, regional heterogeneity of myocardial
perfusion was preserved and flow estimates in infarcted regions
were differentiated more easily from normal regions. Conclu-
sion: The wavelet-based noise-reduction method effectively
and objectively extracted tracer time–activity curves from data
with low signal-to-noise ratios and improved the accuracy and
precision of measurements with all tracer techniques studied.
The approach should be generalizable to other image modalities
such as functional MRI and CT and, therefore, improve the
ability to quantify dynamic physiologic processes.
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Cardiac PET is widely used clinically for the detection
of coronary artery disease and for the assessment of myo-
cardial viability. In addition, it provides a noninvasive ap-
proach to quantify myocardial perfusion and metabolism in
absolute terms. However, PET-based quantification requires
intensive computation of dynamic time–activity curves.
Frequently, images have low signal-to-noise ratios, thus
providing unreliable estimates of physiologic function.
Although PET images with 13NH3 and H215O can measure
myocardial perfusion accurately (1–4), dynamic curves are
noisy at times and regional heterogeneity is high even in the
hearts of healthy volunteers. This is contradictory to the fact
that myocardial perfusion in the healthy subjects should be
relatively homogeneous. In addition, accurate quantification
using data from some tracers (e.g., 82Rb) (5,6) has been
difficult to achieve because of curves with low signal-to-
noise ratios. There is intense interest in using 82Rb because
it is a generator-produced PET flow tracer and can be used
at sites that do not have cyclotrons. Therefore, although
quantification with dynamic PET can provide information in
absolute terms, improvement in the fidelity of the underly-
ing signal is still an important objective.
Several efforts have been made to reduce errors produced
during image processing and data analysis (7–10). One
approach is to apply kernels (mean filters, Gaussian filters,
and so forth) or Fourier frequency filters to raw PET images
or dynamic curves that are obtained from region-of-interest
(ROI) analysis. It is also feasible to design a nonstationary
filter to accommodate local changes and to create low-noise,
high-contrast images (11). In spite of these efforts, image-
based quantification is not always satisfactory and is, by
nature, arbitrary and empiric.
We hypothesized that wavelet transforms and wavelet-
based noise reduction (“denoising”) could be used to im-
prove image-based physiologic quantification with PET.
The wavelet transform expands signals on the basis of
compact (well localized) functions (wavelets). Because
wavelets may have their energies concentrated in time or
space, the wavelet transform, compared with the Fourier
transform that represents a signal purely in the frequency
domain, can simultaneously localize time (or space) and
frequency components. Therefore, multiscale wavelet trans-
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forms are especially well suited for the analysis of nonsta-
tionary signals, such as medical images and time–activity
curves (12).
The wavelet coefficient thresholding and shrinkage
method developed by Donoho and Johnstone (13–15) and
adapted by Lin et al. (16) has several advantages over
conventional smoothing methods. This algorithm trans-
forms a noise-imposed signal into the wavelet domain,
determines the local statistics of wavelet coefficients, finds
a threshold value in the finest level of resolution, shrinks the
amplitude of the coefficients by the threshold, and resyn-
thesizes the signal. Wavelet denoising ensures that the re-
constructed signal is at least as smooth as the underlying
true function. Because of the built-in capacity of local
adaptivity, this approach preserves the rapid rises and falls
of a signal that are usually unintentionally and unavoidably
smoothed by other existing methods. Most important, wave-
let denoising has a solid mathematic background to support
a near-optimal separation of signal and noise. This ability is
objective and mathematically verifiable, whereas improve-
ment with conventional filters is usually determined visually
and empirically.
The aim of this study was to evaluate the effects of
applying wavelet-based noise reduction on improving the
fidelity of image-based physiologic quantification. Quanti-
fication of myocardial perfusion using dynamic PET images
with 82Rb, H215O, and 13NH3 was chosen for this study
because of the importance of flow estimation, the rapid




The institutional review board of the Columbia-Presbyterian
Medical Center approved this study. All subjects signed written
informed consents. All studies were collected on an ECAT
EXACT-47 whole-body PET scanner (CTI/Siemens, Knoxville,
TN). Eighteen healthy volunteers with a low probability of coro-
nary diseases were recruited. Dynamic PET scans using 82Rb and
H215O at rest and after pharmacologic stress with dipyridamole
were obtained on 11 healthy subjects. For these scans, flow was
estimated under resting conditions with 82Rb followed by H215O.
Forty-five minutes after dipyridamole, the sequence was repeated.
Seven subjects repeated the same protocol a few months later.
Seven other healthy volunteers underwent dynamic scanning with
13NH3 at rest and after dipyridamole. Thirteen patients with doc-
umented coronary disease were also enrolled. Each patient had
PET scans with 82Rb and 18F-FDG at rest to assess myocardial
viability. Dipyridamole was not given to these patients.
Imaging Protocols
For 82Rb scans, subjects received a maximum of 0.02 MBq/kg
82Rb given intravenously with an infusion pump. Dynamic scans were
collected for a total of 7 min (thirty-six 5-s frames, eight 15-s frames,
and four 30-s frames). For H215O scans, subjects received a maximum
of 0.01 MBq/kg H215O administered intravenously as a bolus. Dy-
namic scans were collected for a total of 5 min (twenty-four 5-s
frames, six 10-s frames, and eight 15-s frames). After completion of
rest scans, subjects received 0.14 mg/kg/min dipyridamole intrave-
nously for 4 min. Four minutes after the end of the dipyridamole
infusion, subjects again received 82Rb and H215O. The delay between
82Rb and H215O after dipyridamole was ;8 min. In subjects receiving
13NH3, 0.004–0.007 MBq/kg was administered intravenously over
15 s with a constant infusion pump. The emission scan consisted of 16
frames (10 s 3 12, 30 s 3 2, 60 s 3 1, 900 s 3 1) for a total scan time
of 19 min. For healthy subjects receiving dipyridamole, 40–60 min
later, after radioactivity from 13NH3 had returned to background
levels, dipyridamole was administered and the imaging sequence was
repeated.
Quantification of Myocardial Perfusion in Healthy
Volunteers
Emission data were reconstructed and reoriented to short-axis
images using a Hann filter with a cutoff frequency of 0.4 cycle/
pixel giving a natural resolution of 10 mm (full width at half
maximum). The myocardium in each midventricular plane was
defined by circumferential analysis and divided into eight ROIs.
Time–activity curves derived from 82Rb images were fitted to a
previously developed two-compartment model (6) to get flow
estimates. The fitting process without any wavelet-based maneuver
was called the original protocol. The resting and hyperemic esti-
mates for the healthy volunteers were compared with the reference
values that were derived from the validated one-compartment
model fitting with H215O data (3). Flow estimates from 13NH3 were
obtained by fitting the dynamic data to a two-compartment model
(17).
Wavelet-Based Noise Reduction
A discrete dyadic wavelet transform (i.e., with a scaling factor
of 2) developed by Laine and Koren (18–20) was used for signal
analysis and noise reduction in this study. The Fourier transforms
of the wavelet function and the scaling function are shown as
Equations 1 and 2:
C ~v! 5 ~jv!1~sin ~v/4!/~v/4!!4 Eq. 1
F ~v! 5 ~sin ~v/2!/~v/2!!3. Eq. 2
The wavelet analysis used a redundant representation (i.e.,
down sampling and up sampling were not performed during wave-
let expansion and synthesis). This overcomplete representation
resulted in shift invariance, avoided aliasing effect, and, therefore,
ensured the consistency of noise reduction. The method of thresh-
olding and shrinkage developed by Donoho and Johnstone (13–15)
and adapted by Lin et al. (16) was used to perform noise reduction
in this study.
Each midventricular short-axis image of each frame underwent a
two-dimensional wavelet denoising process. The wavelet denoising
algorithm was applied independently to each short-axis image plane
from each frame to remove noise in the spatial domain and then
applied independently to each time–activity curve for each ROI to
remove noise in the temporal domain. The blood time–activity curve
also underwent the denoising process. Time–activity curves from
each of eight ROIs from each short-axis plane were analyzed sepa-
rately. The reconstructed blood and tissue time–activity curves were
fitted to appropriate mathematic models (identical to those used for
the original protocol) to get flow estimates. Data from healthy volun-
teers were averaged to provide one mean flow for a heart, but
region-to-region variability in flow estimates was also measured. We
defined this approach as the wavelet protocol.
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Comparison of Original Protocol and Wavelet Protocol
in Healthy Volunteers
The precision of quantification results derived from perfusion
images was defined as the ratio of a flow estimate to its associated
SE (i.e., the estimate-to-error ratio). The SE resulted from the
calculation of the second derivatives of the error function with the
values of the optimized estimates. The median of the estimate-to-
error ratios of all ROIs was used as an indicator of overall preci-
sion for a specific study. Comparison was made between the
original protocol and the wavelet protocol at rest and after phar-
macologic stress.
The accuracy of the flow estimates obtained from the original
protocol and the wavelet protocol using 82Rb images was verified
by the reference values obtained from the model fitting with H215O
data. The distribution of differences among the two measurements
of all ROIs in all healthy volunteers was found at rest and after
pharmacologic stress.
Application of Wavelet Analysis to H215O and 13NH3
Data
In a separate analysis, data derived from H215O and 13NH3
images underwent the same wavelet-denoising process. The de-
noised data were fitted to their respective models to get flow
estimates. The precision in terms of median estimate-to-error ratio
was calculated and compared with original estimates.
The coefficients of variation (COVs) (i.e., the ratio of the SD to
the average flow in all ROIs) of each healthy subject were used as
an indicator of inter-regional heterogeneity. The COV was calcu-
lated for each study at rest or after pharmacologic stress.
Comparison of Differentiating Capacity Obtained from
Original Protocol with That Derived from Wavelet
Protocol in Patients
Myocardial flow was also estimated using dynamic PET with
82Rb in 13 patients undergoing viability scanning. Three experi-
enced nuclear cardiologists were asked to read count-based image
sets of 82Rb and FDG scans for the patients. Each ROI in the study
was categorized as normal, ischemic but viable, or infarcted.
Normal tissue was defined as regions with normal myocardial
perfusion and FDG uptake, ischemic regions were defined as those
with diminished perfusion but near-normal FDG uptake, and in-
farcted zones were defined as those with myocardial perfusion ,
50% of maximum with a matched decreased in FDG uptake.
Differences were resolved by consensus. Flow estimates in the
normal regions and infarcted regions were compared without and
with the wavelet protocol. The number of ischemic but viable




Dynamic curves derived from 82Rb images can be viewed
through the temporal and the spatial domains. The temporal
view shows the shape of time–activity curves over time. The
blood and tissue time–activity curves retained the dynamic
shapes (including the early peaks), and the inherent noise
was removed (16,19).
The spatial view represents the radioactivity among all
ROIs in the whole heart at a given time. Figure 1 shows
regional radioactivity of all ROIs in the last frame (390th to
420th second) of the resting 82Rb scan in one patient with
myocardial infarction in the anterior and septal regions. The
regional radioactivity derived from raw images was noisy so
that the continuity among adjacent regions was not ob-
served. However, the wavelet protocol restored the smooth-
ness of radioactivity in the whole heart and still preserved
the regional variation.
Precision and Accuracy
The median estimate-to-noise ratio for myocardial perfu-
sion in all resting 82Rb studies in healthy volunteers (n 5
18) was 2.28 6 0.65 with the original protocol and 10.70 6
3.45 with the wavelet protocol, equivalent to a gain of 4.85
(P , 0.001) (Fig. 2). The estimate-to-noise ratio in all
hyperemic 82Rb studies (n 5 14) was 2.07 6 0.68 before
and 9.93 6 3.69 after the wavelet approach (Fig. 2). The
gain was 5.01 (P , 0.001).
Flow estimates derived from 82Rb images were compared
with those from original H215O estimates on a region-by-
region basis. Results derived from unmodified 82Rb data
slightly overestimated flow compared with estimates ob-
tained with H215O (0.05 6 0.80 mL/g/min at rest and 0.53 6
1.57 mL/g/min after dipyridamole; n 5 560 ROIs at rest
compared with 448 ROIs after dipyridamole) and had ex-
FIGURE 1. Count-based regional ra-
dioactivity in last frame of 82Rb scan in
patient with myocardial infarction before
(A) and after (B) wavelet denoising. x-axis
represents eight ROIs in each plane (from
inferior region 1 counterclockwise to sep-
tal), y-axis represents average radioactiv-
ity (nCi/pixel/s) in ROI, and z-axis repre-
sents short-axis planes (from base to
apex). Regional radioactivity in original
dataset for entire heart was distorted by
inherent noise (A). Wavelet approach
maintained smoothness and continuity
among regions but still preserved re-
gional variation (B).
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tremely wide variation (Fig. 3). The difference in resting
flows was 20.09 6 0.20 mL/g/min and 20.04 6 0.56
mL/g/min after dipyridamole using the wavelet protocol.
Thus, the bias and variation in comparison with H215O were
significantly reduced by wavelet denoising (Fig. 3).
Flow Estimates Derived from H215O and 13NH3
The estimate-to-error ratios of resting flow derived from
H215O data from healthy volunteers was 5.16 6 0.84 before
and 8.70 6 1.12 after wavelet noise reduction (P , 0.001)
yielding a gain of 1.72. The precision for hyperemic flow
was 4.84 6 1.37 before and 9.60 6 2.02 after wavelet
denoising (P , 0.001) with a gain of 2.25 (Fig. 4A). The
COVs of inter-regional flow were reduced from 31% 6 6%
to 9% 6 2% at rest (P , 0.001) and from 30% 6 6% to
14% 6 5% after hyperemia (P , 0.001) using the wavelet
approach (Fig. 4B). Thus, the wavelet approach signifi-
cantly improved the precision of flow estimates and reduced
inter-regional heterogeneity.
Flow estimates derived from 13NH3 data also showed
improved precision and decreased heterogeneity after wave-
let processing. Estimate-to-error ratios increased from
4.94 6 0.61 to 8.95 6 3.72 at rest (P , 0.001) and from
7.70 6 1.87 to 13.36 6 4.51 with hyperemia (P , 0.001)
after wavelet denoising (n 5 7) (Fig. 5A). The COV de-
creased from 23% 6 6% to 7% 6 4% at rest (P , 0.001)
and from 18% 6 4% to 6% 6 1% with hyperemia (P ,
0.001) after the wavelet process (Fig. 5B).
Flow Estimates in Normal and Infarcted Regions
Flow estimates in the normal and infarcted regions were
compared according to the categorization of three special-
ists. Figure 6 shows the flow distribution in infarcted and
normal territories in patients. Because of the poor precision
derived from the original protocol, the distributions of flows
in the normal and infarcted regions were wide and over-
lapped with each other. Without the denoising process, the
original protocol failed to differentiate regions with normal
perfusion from those with low perfusion. The wavelet pro-
tocol successfully separated the flow in these two states
(Fig. 6). Flow derived from 82Rb after the wavelet protocol
was 0.71 6 0.15 mL/g/min in the normal regions and
0.53 6 0.14 mL/g/min in infarcted regions (P , 0.001). The
wavelet approach consistently differentiated normal from
infarcted regions in all patients.
DISCUSSION
Although PET is a powerful tool for analyzing various
physiologic functions, this study indicates that quantifica-
tion of myocardial perfusion using uncorrected data derived
from 82Rb images cannot produce accurate estimates be-
cause dynamic curves are noisy. On the other hand, wavelet
analysis and processing provided a robust approach to ob-
tain accurate and precise myocardial flow and to differen-
tiate normal from abnormal regions.
The wavelet-denoising algorithm evaluates local statis-
tics, performs locally adaptive spatial and temporal smooth-
FIGURE 2. Median estimate-to-error ratios derived from 82Rb
data before (original) and after wavelet denoising at rest and
during hyperemia. Wavelet approach improved estimate-to-
noise ratio (P , 0.001 for both). Values are expressed as
mean 6 SD.
FIGURE 3. Distribution of differences
between flows derived from 82Rb studies
and those from H215O studies. (A) Differ-
ences in resting flows with original proto-
col (0.05 6 0.80 mL/g/min) and wavelet
protocol (20.09 6 0.20 mL/g/min). (B)
Differences in hyperemic flows with orig-
inal protocol (0.53 6 1.57 mL/g/min) and
wavelet protocol (20.04 6 0.56 mL/g/
min). Wavelet protocol reduced differ-
ences between two measurements (P ,
0.001 for both). Values are expressed as
mean 6 SD.
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ing, separates signal and noise, and reconstructs signals that
can be fitted to obtain accurate estimates. Wavelet analysis
has the ability to adapt to local variation and also has a
theoretic proof for finding a near-optimal approximation to
an underlying function. This approach can spot and preserve
rapid changes in a signal and separate affected and unaf-
fected regions. Therefore, the results in this study show that
wavelet transformations and analysis are powerful tools for
maintaining the fidelity of multidimensional signals in
noise-limited images.
The fidelity of time–activity data improved the quantita-
tive results in several ways. First, the wavelet protocol
significantly increased the precision of flow estimates. The
estimate-to-error ratio increased about 5-fold in 82Rb stud-
ies, whereas the size of ROIs remained the same (;0.70–
0.85 cm3). Therefore, the need to sacrifice the information
of detailed textures in return for better statistical stability
was eliminated.
Second, the wavelet protocol resulted in regional esti-
mates derived from 82Rb images using the two-compartment
model as accurate as those derived from H215O images using
the one-compartment model. Although the wavelet method
produced a slight bias (20.09 mL/g/min) in resting studies,
the significant reduction in the variation of difference be-
tween the two measurements outperformed the original pro-
tocol and ensured the reliability of regional estimates (Fig.
3A). For the stress studies, bias and variation were signifi-
cantly reduced by wavelet processing (Fig. 3B). The mean
bias (20.04 mL/g/min) can be ignored compared with the
relative hyperemia (;2.5–3.5 mL/g/min). Therefore, the
wavelet protocol improved the accuracy of regional flow
estimates.
Third, this multidimensional wavelet protocol increased
the precision and decreased the heterogeneity of flow esti-
mates derived from 82Rb as well as those obtained with
H215O and 13NH3. Previous studies from our laboratory (3)
FIGURE 4. Estimate-to-error ratios (A) and COVs of flow estimates (B) derived from H215O data before and after wavelet-based
noise reduction at rest and during hyperemia. Wavelet approach improved precision and reduced regional variation (P , 0.001 for
both). Values are expressed as mean 6 SD.
FIGURE 5. Estimate-to-error ratios (A) and COVs of flow estimates (B) derived from 13NH3 data before and after wavelet-based
noise reduction at rest and during hyperemia. Wavelet approach improved precision and reduced regional variation (P , 0.001
for both). Values are expressed as mean 6 SD.
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have shown that regional COV in studies from healthy
volunteers evaluated with H215O averages ;20%–35%
(3,20). This is similar to values that have been observed in
experimental studies (21). The gain in precision with 82Rb is
more significant than that with the other two tracers (five-
fold with 82Rb and 2-fold with H215O and 13NH3) because
the inherent signal-to-noise ratio is lower in 82Rb images. In
addition, wavelet processing did not markedly influence the
absolute value of global flows derived from either H215O or
13NH3. However, flow estimates with 82Rb decreased after
wavelet denoising because of improved data accuracy (19)
(Table 1).
Quantitative measurements also proved that flow esti-
mates in the normal and infarcted regions could be discrim-
inated. Therefore, the improvement in the precision and
accuracy of flow estimates was not simply associated with
oversmoothing. Instead, the wavelet approach exhibits a
built-in local adaptivity that detected the transition between
normal and infarcted regions. This local adaptivity not only
contributed to the differentiating capacity in the spatial
domain but also preserved the early upstrokes of blood and
time–activity curves (the temporal domain), essential fea-
tures for getting accurate flow estimates.
Most important, the denoising process followed an ob-
jective algorithm that performed wavelet thresholding and
shrinkage. Under the assumption of containing a series of
normally distributed errors, this algorithm near-optimally
separated noise and signal according to the local statistics of
wavelet components. The best smoothing effect was math-
ematically, rather than visually or empirically, determined.
Therefore, although PET images from different scans might
contain various levels of noise, the described wavelet pro-
tocol automatically found an ideal amount to smooth with-
out the need of empiric trial and error. This characteristic
enabled the wavelet approach to be generalizable to the
evaluation of other parameters in the same compartment
model or to quantification using PET with different radio-
active tracers.
CONCLUSION
In this study, we showed that the wavelet method suc-
cessfully improved the precision of flow estimates and
reduced the inter-regional heterogeneity in the hearts of
healthy volunteers with the use of three different flow
tracers. Because of the similarity of the problems and the
methods, the use of wavelet-based noise reduction and
signal maintenance has significant potential to improve in-
formation acquisition from various imaging modalities such
as SPECT, CT, and MRI. Therefore, the wavelet method
should prove to be a robust approach to improve image
quantification and fidelity.
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Original Wavelet n Original Wavelet n Original Wavelet n
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Same subjects received 82Rb and H215O, whereas seven different subjects received 13NH3. Mean flow decreased after wavelet protocol
with 82Rb because of improved estimates.
FIGURE 6. Flow estimates in normal and infarcted regions in
patients with myocardial infarction using 82Rb at rest. Before
wavelet denoising (Original), flow estimates had wide distribu-
tions and significant overlap. After wavelet denoising (Wavelet),
flow estimates in normal and infarcted regions were clearly
separated. Values are expressed as mean 6 SD. MBF 5 myo-
cardial blood flow.
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